Cipher Pharmaceuticals Inc (TSE:CPH) (NASDAQ:CPHR) fell 0% during mid-day trading on Thursday . The stock traded as low as C$4.42 and last traded at C$4.42. 12,700 shares changed hands during mid-day trading, an increase of 6% from the average session volume of 11,964 shares. The stock had previously closed at C$4.42.
Separately, TD Securities lowered their price objective on shares of Cipher Pharmaceuticals from C$6.50 to C$5.00 and set a “hold” rating for the company in a research report on Tuesday, November 7th.
The firm has a market cap of $118.10, a PE ratio of -20.09 and a beta of 1.54.
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals Inc, together with its subsidiaries, operates as a specialty pharmaceutical dermatology company in South America, Canada, and the United States. It offers CIP-ISOTRETINOIN, a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; CIP-FENOFIBRATE, a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and CIP-TRAMADOL ER, a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain.
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.